RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer ; volume:14 ; number:1 ; day:30 ; month:10 ; year:2024 ; pages:1-17 ; date:12.2024
Scientific reports ; 14, Heft 1 (30.10.2024), 1-17, 12.2024
- Creator
-
Li, Tingjun
Huang, Yiqin
Cui, Shien
Hong, Zhipeng
Zhang, Xinhai
Li, Zhihao
Chen, Kunqi
Chen, Debo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-77941-2
- URN
-
urn:nbn:de:101:1-2501192134586.566091738891
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Tingjun
- Huang, Yiqin
- Cui, Shien
- Hong, Zhipeng
- Zhang, Xinhai
- Li, Zhihao
- Chen, Kunqi
- Chen, Debo
- SpringerLink (Online service)
Other Objects (12)
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer
Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect
Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer
Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect
Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer
Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect
Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer